New Business Win: Callidus Software Signs Another Pharma Customer in On-Premise Subscription Deal
SAN JOSE, CA--(Marketwire - November 3, 2009) - Callidus Software Inc. (
"Our life science momentum continues apace with this agreement," said Jeff Saling, senior vice president of global sales at Callidus Software. "Sales Performance Management is critical to the life sciences industry. This deal is significant in that it is provided under the terms of our new term license model for on-premise customers. This approach provides a much more cost effective way for customers to get the industry's leading SPM solution. At the same time, it adds to Callidus' cumulative annual contract value (ACV) and annual recurring revenue. This solution will serve 2,900 payees and replace an expensive and inflexible legacy competitor."
The Callidus SPM Suite provides an end-to-end performance management platform. It enables businesses to optimize the entire sales lifecycle from sales on-boarding, to quota and plan deployment and payment. This helps deliver a [ high ROI ] in a very short period of time. The company's solutions give actionable insight into sales execution and channel operations and provide the tools to fine-tune sales performance.
For more news on sales performance management, follow Callidus on [ LinkedIn ], [ Facebook ] and [ Twitter ].
About Callidus Software®
Callidus Software ([ www.callidussoftware.com ]) (
© 1998-2009 Callidus Software Inc. All rights reserved. Callidus Software, the Callidus Software logo, Callidus TrueAnalytics, TrueChannel, TrueComp, TrueComp Grid, TrueComp Manager, TrueConnection, TrueFoundation, TrueInformation, TruePerformance, TruePerformance Index, TruePerformance Indicator, TrueMBO, TrueAllocation, TrueProducer, TrueQuota, TrueReferral, TrueResolution, TrueTarget and TrueService+ are trademarks, servicemarks, or registered trademarks of Callidus Software Inc. in the United States and other countries. All other brand, service or product names are trademarks or registered trademarks of their respective companies or owners.